Clinical outcomes of carbapenem therapy in OXA-48–producing Enterobacterales infections: a French multicentre cohort, systematic review, and meta-analysis

OXA-48–producing Enterobacterales (OXA-48-PE) represent a growing global health threat. Most of OXA-48–PE remain categorized susceptible to carbapenems, which might encourage their use despite uncertain clinical efficacy. This study evaluated clinical outcomes of infections caused by OXA-48-PE treat...

Full description

Bibliographic Details

Published in:	Emerging Microbes and Infections
Main Authors:	Laurent Dortet, Charlotte Moreau, Aurélien Dinh, Rémy A. Bonnin, Lélia Escaut, Manon Seguret, Laura Weber, Samy Figueiredo, Benoît Pilmis
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2026-12-01
Subjects:	OXA-48 carbapenemase-producing Enterobacterales carbapenem therapy ceftazidime-avibactam antimicrobial resistance meta-analysis
Online Access:	https://www.tandfonline.com/doi/10.1080/22221751.2026.2671518